| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5282490
Max Phase: Preclinical
Molecular Formula: C18H15ClN6O
Molecular Weight: 366.81
Associated Items:
Representations
Canonical SMILES: COc1ccc(Nc2ncnc3c2cnn3-c2ccc(C)nc2)cc1Cl
Standard InChI: InChI=1S/C18H15ClN6O/c1-11-3-5-13(8-20-11)25-18-14(9-23-25)17(21-10-22-18)24-12-4-6-16(26-2)15(19)7-12/h3-10H,1-2H3,(H,21,22,24)
Standard InChI Key: LJAWNHWVGXQZCK-UHFFFAOYSA-N
Associated Targets(Human)
Phosphatidylinositol-5-phosphate 4-kinase type-2 alpha 1501 Activities
PI3-kinase p110-gamma subunit 5411 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 366.81 | Molecular Weight (Monoisotopic): 366.0996 | AlogP: 3.92 | #Rotatable Bonds: 4 |
| Polar Surface Area: 77.75 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 5.26 | CX LogP: 2.92 | CX LogD: 2.91 |
| Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.59 | Np Likeness Score: -2.06 |
References
| 1. Willems HMG, Edwards S, Boffey HK, Chawner SJ, Green C, Romero T, Winpenny D, Skidmore J, Clarke JH, Andrews SP.. (2023) Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor., 14 (5): [PMID:37252102] [10.1039/d3md00039g] |
Source
Source(1):